Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 162
Filtrar
1.
Nutrition ; 122: 112391, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38460446

RESUMO

OBJECTIVES: Skeletal muscle index (SMI) is insufficient for evaluating muscle in obesity, and muscle attenuation (MA) may be a preferred indicator. This study aimed to investigate whether MA has greater prognostic value than SMI in gastric cancer patients with overweight and obesity. METHODS: Clinical parameters of 1312 patients with gastric cancer who underwent radical gastrectomy were prospectively collected between 2013 and 2019. MA and SMI were analyzed by computed tomography scan. Overweight/obesity was defined as body mass index (BMI) ≥24 kg/m2. The hazard ratio (HR) for death was calculated using Cox regression analysis. RESULTS: Among all patients, 405 were identified as overweight and obese, and 907 were identified as normal and underweight. MA was inversely associated with BMI and visceral fat area. Among the 405 patients with overweight and obesity, 212 patients (52%) were diagnosed with low MA. In the overweight/obese group, MA was an independent predictor for overall survival (HR, 1.610; P = 0.021) in multivariate Cox regression analyses, whereas SMI did not remain in the model. In the normal/underweight group, both low MA (HR, 1.283; P = 0.039) and low SMI (HR, 1.369; P = 0.008) were independent factors of overall survival. Additionally, 318 patients were identified as having visceral obesity in the overweight/obese group, and low MA was also an independent prognostic factor for survival in these patients (HR, 1.765; P = 0.013). CONCLUSION: MA had a higher prognostic value than SMI in overweight and obese patients with gastric cancer after radical gastrectomy.


Assuntos
Sarcopenia , Neoplasias Gástricas , Humanos , Sobrepeso/complicações , Sobrepeso/patologia , Prognóstico , Neoplasias Gástricas/complicações , Neoplasias Gástricas/cirurgia , Sarcopenia/complicações , Magreza/complicações , Músculo Esquelético/diagnóstico por imagem , Músculo Esquelético/patologia , Obesidade/complicações , Obesidade/patologia , Estudos Retrospectivos
2.
J Clin Endocrinol Metab ; 109(1): e253-e258, 2023 Dec 21.
Artigo em Inglês | MEDLINE | ID: mdl-37490040

RESUMO

CONTEXT: Hepatic steatosis is associated with decreased bone mineral density (BMD). Bone marrow fat fraction (BMFF) could play a role in this relationship in children with obesity. OBJECTIVE: The objectives of this work were (i) to examine the relationship between the lumbar spine (LS) BMFF and BMD, and (ii) to explore the mediating role of LS-BMFF on the relationship between percentage hepatic fat with LS-BMD in preadolescent children with overweight/obesity. METHODS: Hepatic fat and LS-BMFF (magnetic resonance imaging) and areal LS-BMD (LS-aBMD, dual-energy x-ray absorptiometry) were measured in 106 children (aged 10.6 ± 1.1 years, 53.8% girls) with overweight/obesity. RESULTS: LS-BMFF was inversely associated with LS-aBMD (r = -0.313; P = .001) and directly related with percentage hepatic fat (r = 0.276; P = .005). LS-BMFF was significantly greater in children with than without hepatic steatosis (P = .003; Cohen's d: 0.61; 95% CI, -0.21 to 1.0), while no significant difference was seen between children with overweight and those with obesity (P = .604; Cohen's d: 0.16; 95% CI, -0.21-0.55). Mediating analysis indicated that LS-BMFF is an important mediator (50%) in the association of hepatic fat with lower LS-aBMD (indirect effect: ß = -.076; 95% CI, -0.143 to -0.015). CONCLUSION: These findings suggest that hepatic steatosis, rather than overall excess adiposity, is associated with greater bone marrow adipose tissue in preadolescent children with overweight/obesity, which in turn, is related to lower BMD. Hepatic steatosis could be a potential biomarker of osteoporosis risk, and a therapeutic target for interventions that aim to reduce not only hepatic steatosis, but for those designed to improve bone health in such children.


Assuntos
Densidade Óssea , Fígado Gorduroso , Feminino , Criança , Humanos , Masculino , Sobrepeso/complicações , Sobrepeso/patologia , Medula Óssea/diagnóstico por imagem , Medula Óssea/patologia , Obesidade/patologia , Tecido Adiposo/diagnóstico por imagem , Tecido Adiposo/patologia , Absorciometria de Fóton , Fígado Gorduroso/diagnóstico por imagem , Fígado Gorduroso/patologia , Vértebras Lombares
3.
Sci Rep ; 12(1): 21925, 2022 12 19.
Artigo em Inglês | MEDLINE | ID: mdl-36535977

RESUMO

Non-invasive imaging techniques have greatly advanced the assessment of liver fibrosis and steatosis but are not fully evaluated in overweight patients. We evaluated the diagnostic performance of vibration-controlled transient elastography (VCTE) and magnetic resonance elastography (MRE) to assess fibrosis and controlled attenuation parameter (CAP) and MR imaging (MRI)-proton density fat fraction (MRI-PDFF) to assess steatosis in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD). We included 163 biopsy-proven patients with NAFLD who underwent VCTE, MRE/MRI-PDFF, and liver biopsy (years 2014-2020) who were classified according to their body mass index (BMI) as normal (BMI < 25 kg/m2, n = 38), overweight (25 ≤ BMI < 30 kg/m2, n = 68), and obese (BMI ≥ 30 kg/m2, n = 57). VCTE and MRE detected fibrosis of stages ≥ 2, ≥ 3, and 4 with an area under the receiver operating curve (AUROC) of 0.83-0.94 (VCTE) and 0.85-0.95 (MRE) in all groups, without considerable differences. MRI-PDFF detected steatosis of grades ≥ 2 and 3 with high AUROC in all groups (0.81-1.00). CAP's diagnostic ability (0.63-0.95) was lower than that of MRI-PDFF and decreased with increasing BMI compared to MRI-PDFF. VCTE and MRE similarly accurately assess fibrosis, although MRI-PDFF is more accurate than CAP in detecting steatosis in overweight and obese patients with NAFLD.


Assuntos
Técnicas de Imagem por Elasticidade , Hepatopatia Gordurosa não Alcoólica , Humanos , Hepatopatia Gordurosa não Alcoólica/patologia , Técnicas de Imagem por Elasticidade/métodos , Fígado/patologia , Sobrepeso/patologia , Vibração , Curva ROC , Cirrose Hepática/patologia , Obesidade/patologia , Imageamento por Ressonância Magnética/métodos
4.
Med Sci (Basel) ; 10(3)2022 08 09.
Artigo em Inglês | MEDLINE | ID: mdl-35997334

RESUMO

Colorectal cancer (CRC) is the third leading cause of cancer-related death. We aimed to investigate the clinicopathological characteristics and 5-year survival in CRC. This retrospective study reviewed King Abdulaziz University Hospital records from 2009 to 2019. Tumor staging was performed using Dukes' pathological classification. Additionally, we measured the frequency of qualitative data and performed the chi-square and Mann−Whitney U-tests. Kaplan−Meier analysis was performed to calculate overall survival. Of the 574 included patients (age (mean ± standard deviation), 55.51 ± 14.28 years), 43.2% were Saudis, and most were male (58.7%). The rectum was the most common location of CRC (30.8%); 33.1% of patients presented with abdominal pain. The dominant histological variant was mucinous adenocarcinoma (95.5%). Age at diagnosis was significantly associated with Dukes' staging; 36.3% of individuals aged <50 years had Dukes' D stage. The 5-year survival rate was 47.9%. Better survival was noted for those of Saudi nationality, those with Dukes' A stage, and those who were overweight (51.6%, 56.3%, and 46.8%, respectively). Significantly better survival was seen in Saudi patients due to accessible healthcare and in overweight patients due to better treatment tolerance. The outcome of CRC was not related to sex or metformin use in patients with diabetes mellitus.


Assuntos
Neoplasias Colorretais , Neoplasias Colorretais/patologia , Neoplasias Colorretais/terapia , Feminino , Humanos , Masculino , Estadiamento de Neoplasias , Sobrepeso/patologia , Prognóstico , Estudos Retrospectivos
5.
Int J Obes (Lond) ; 46(10): 1735-1741, 2022 10.
Artigo em Inglês | MEDLINE | ID: mdl-35778479

RESUMO

AIM: This study aimed to discover the effects of coconut oil intake and diet therapy on anthropometric measurements, biochemical findings and irisin levels in overweight individuals. MATERIALS AND METHODS: Overweight individuals (n = 44, 19-30 years) without any chronic disease were included. In this randomized controlled crossover study, the participants were divided into two groups (Group 1: 23 people, Group 2: 21 people). In the first phase, Group 1 received diet therapy to lose 0.5-1 kg of weight per week and 20 mL of coconut oil/day, while Group 2 only received diet therapy. In the second phase, Group 1 received diet therapy while Group 2 received diet therapy and 20 mL of coconut oil/day. Anthropometric measurements were taken four times. Irisin was measured four times by enzyme-linked immunosorbent (ELISA) method and other biochemical findings were measured twice. Statistical analysis was made on SPSS 20. RESULTS: The irisin level decreased significantly when the participants only took coconut oil (p ≤ 0.05). There was a significant decrease in the participants' body weight, body mass index (BMI) level and body fat percentage (p ≤ 0.01). Insulin, total cholesterol, low density lipoproteins (LDL) cholesterol, and triglyceride (TG) levels of all participants decreased significantly (p ≤ 0.05). There was no significant difference in irisin level due to body weight loss (p ≤ 0.05); coconut oil provided a significant decrease in irisin level (p ≤ 0.05). CONCLUSION: Diet therapy and weight loss did not have an effect on irisin level, but coconut oil alone was found to reduce irisin level. Coconut oil had no impact on anthropometric and biochemical findings.


Assuntos
Óleo de Coco , Fibronectinas , Sobrepeso , Redução de Peso , Adulto , Antropometria , Colesterol/sangue , Óleo de Coco/farmacologia , Óleo de Coco/uso terapêutico , Estudos Cross-Over , Fibronectinas/sangue , Humanos , Insulinas/sangue , Lipoproteínas LDL , Sobrepeso/dietoterapia , Sobrepeso/patologia , Triglicerídeos/sangue , Adulto Jovem
6.
J Gastroenterol Hepatol ; 37(10): 1901-1910, 2022 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-35790343

RESUMO

BACKGROUND AND AIM: The aim of this study was to assess the impact of body mass index (BMI) on the clinical and histological characteristics of patients with nonalcoholic fatty liver disease (NAFLD). METHODS: Patients with clinically diagnosed NAFLD who received liver biopsy were retrospectively enrolled from 2007 to 2019. For comparison, all of the patients were divided into lean body mass (< 23 kg/m2 ), overweight (23-24.9 kg/m2 ), and obesity (BMI â‰§ 25 kg/m2 ). RESULTS: A total of 572 patients with histologically confirmed NAFLD, including 40 (6.99%) lean body mass, 54 (9.44%) overweight, and 478 (83.57%) obese patients, were recruited. Obese NAFLD patients had significantly higher grade of steatosis (grade 3: 29.92% vs 22.22% vs 12.5%, P < 0.0001) and hepatocyte ballooning (grade 2: 14.85% vs 12.96% vs 12.5%, P < 0.0001) than overweight and lean NAFLD patients. The prevalence of nonalcoholic steatohepatitis (NASH) was 22.5%, 25.93%, and 36.19% in lean, overweight, and obese NAFLD patients, respectively. Obesity was significantly associated with fibrosis severity (P = 0.03). The fibrosis index based on four factors (FIB-4) score can identify NAFLD patients without significant fibrosis or with cirrhosis. The areas under the receiver-operating characteristic curve of FIB-4 score to identify patients without significant fibrosis or with cirrhosis were 0.82 (95% confidence interval [CI]: 0.69-0.96) and 0.87 (95% CI: 0.76-0.99) in lean patients; 0.77 (95% CI: 0.61-0.93) and 0.81 (95% CI: 0.59-1.0) in overweight patients; and 0.77 (95% CI: 0.72-0.82) and 0.89 (95% CI: 0.85-0.92) in obese patients. CONCLUSIONS: The majority of NAFLD patients are obese, as defined by BMI. Obesity was significantly associated with NASH and hepatic fibrosis severity in patients with NAFLD.


Assuntos
Hepatopatia Gordurosa não Alcoólica , Biópsia , Índice de Massa Corporal , Humanos , Fígado/patologia , Cirrose Hepática/complicações , Cirrose Hepática/etiologia , Hepatopatia Gordurosa não Alcoólica/complicações , Hepatopatia Gordurosa não Alcoólica/epidemiologia , Hepatopatia Gordurosa não Alcoólica/patologia , Obesidade/complicações , Obesidade/epidemiologia , Obesidade/patologia , Sobrepeso/complicações , Sobrepeso/epidemiologia , Sobrepeso/patologia , Estudos Retrospectivos , Taiwan/epidemiologia
7.
Pain ; 163(9): 1800-1811, 2022 09 01.
Artigo em Inglês | MEDLINE | ID: mdl-35239546

RESUMO

ABSTRACT: Defined by dysfunction or degeneration of Aδ and C fibers, small fiber neuropathies (SFNs) entail a relevant health burden. In 50% of cases, the underlying cause cannot be identified or treated. In 100 individuals (70% female individuals; mean age: 44.8 years) with an idiopathic, skin biopsy-confirmed SFN, we characterized the symptomatic spectrum and measured markers of oxidative stress (vitamin C, selenium, and glutathione) and inflammation (transforming growth factor beta, tumor necrosis factor alpha), as well as neurotoxic 1-deoxy-sphingolipids. Neuropathic pain was the most abundant symptom (95%) and cause of daily life impairment (72%). Despite the common use of pain killers (64%), the painDETECT questionnaire revealed scores above 13 points in 80% of patients. In the quantitative sensory testing (QST), a dysfunction of Aδ fibers was observed in 70% and of C fibers in 44%, affecting the face, hands, or feet. Despite normal nerve conduction studies, QST revealed Aß fiber involvement in 46% of patients' test areas. Despite absence of diabetes mellitus or mutations in SPTLC1 or SPTLC2 , plasma 1-deoxy-sphingolipids were significantly higher in the sensory loss patient cluster when compared with those in patients with thermal hyperalgesia ( P < 0.01) or those in the healthy category ( P < 0.1), correlating inversely with the intraepidermal nerve fiber density (1-deoxy-SA: P < 0.05, 1-deoxy-SO: P < 0.01). Patients with arterial hypertension, overweight (body mass index > 25 kg/m 2 ), or hyperlipidemia showed significantly lower L-serine (arterial hypertension: P < 0.01) and higher 1-deoxy-sphingolipid levels (arterial hypertension: P < 0.001, overweight: P < 0.001, hyperlipidemia: P < 0.01). Lower vitamin C levels correlated with functional Aß involvement ( P < 0.05). Reduced glutathione was lower in patients with Aδ dysfunction ( P < 0.05). Idiopathic SFNs are heterogeneous. As a new pathomechanism, plasma 1-deoxy-sphingolipids might link the metabolic syndrome with small fiber degeneration.


Assuntos
Hipertensão , Neuropatia de Pequenas Fibras , Adulto , Ácido Ascórbico , Feminino , Humanos , Masculino , Sobrepeso/patologia , Estresse Oxidativo , Pele/inervação , Esfingolipídeos
8.
Sci Rep ; 11(1): 19859, 2021 10 06.
Artigo em Inglês | MEDLINE | ID: mdl-34615918

RESUMO

Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of cardiometabolic diseases in overweight individuals. While liver biopsy is the current gold standard to diagnose NAFLD and magnetic resonance imaging (MRI) is a non-invasive alternative still under clinical trials, the former is invasive and the latter costly. We demonstrate electrical impedance tomography (EIT) as a portable method for detecting fatty infiltrate. We enrolled 19 overweight subjects to undergo liver MRI scans, followed by EIT measurements. The MRI images provided the a priori knowledge of the liver boundary conditions for EIT reconstruction, and the multi-echo MRI data quantified liver proton-density fat fraction (PDFF%) to validate fat infiltrate. Using the EIT electrode belts, we circumferentially injected pairwise current to the upper abdomen, followed by acquiring the resulting surface-voltage to reconstruct the liver conductivity. Pearson's correlation analyses compared EIT conductivity or MRI PDFF with body mass index, age, waist circumference, height, and weight variables. We reveal that the correlation between liver EIT conductivity or MRI PDFF with demographics is statistically insignificant, whereas liver EIT conductivity is inversely correlated with MRI PDFF (R = -0.69, p = 0.003, n = 16). As a pilot study, EIT conductivity provides a portable method for operator-independent and cost-effective detection of hepatic steatosis.


Assuntos
Impedância Elétrica , Fígado Gorduroso/diagnóstico por imagem , Fígado Gorduroso/patologia , Sobrepeso/patologia , Tomografia/métodos , Adulto , Idoso , Algoritmos , Biomarcadores , Biópsia , Pesos e Medidas Corporais , Gerenciamento Clínico , Feminino , Humanos , Processamento de Imagem Assistida por Computador , Imageamento por Ressonância Magnética/métodos , Masculino , Pessoa de Meia-Idade , Reprodutibilidade dos Testes , Fatores de Risco , Sensibilidade e Especificidade
9.
PLoS One ; 16(8): e0256809, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34449806

RESUMO

BACKGROUND: At the population level we would expect that people with obesity undergo diabetes screening tests more often than people with overweight and much more often than people with normal weight. We described the trends of diabetes screening according to body mass index (BMI) and waist circumference (WC) in Peru. METHODS: Pooled analysis of health national surveys (2015-2019); men and women aged 35-70 years. We used relative frequencies to study: among those who have had a glucose test in the last year, how many there were in each BMI and WC category. We fitted a Poisson model to study whether people with high BMI or WC were more likely to have had a glucose test. RESULTS: People with overweight (PR = 1.34; 95% CI: 1.29-1.38), obesity (PR = 1.57; 95% CI: 1.51-1.63) and central obesity (PR = 1.63; 95% CI: 1.35-1.96) were more likely to have had a glucose test. At the sub-national level, there was one (of twenty-five) region in which men with obesity were more often screened for diabetes than men with overweight and much more than men with normal weight. There were seven regions in which women with obesity were the most often screened for diabetes. CONCLUSIONS: Consistent with a risk-based prevention approach, people with obesity would be screened for diabetes more often than those with overweight and those with normal weight. This ideal profile was only observed in few regions. Diabetes screening strategies should be strengthened and homogenised, so that they reach those at high risk of diabetes.


Assuntos
Diabetes Mellitus/diagnóstico , Hipertensão/diagnóstico , Obesidade Abdominal/diagnóstico , Sobrepeso/diagnóstico , Adulto , Índice de Massa Corporal , Diabetes Mellitus/sangue , Diabetes Mellitus/epidemiologia , Diabetes Mellitus/patologia , Feminino , Inquéritos Epidemiológicos , Humanos , Hipertensão/sangue , Hipertensão/epidemiologia , Hipertensão/patologia , Masculino , Programas de Rastreamento/métodos , Pessoa de Meia-Idade , Obesidade Abdominal/sangue , Obesidade Abdominal/epidemiologia , Obesidade Abdominal/patologia , Sobrepeso/sangue , Sobrepeso/epidemiologia , Sobrepeso/patologia , Peru/epidemiologia , Fatores de Risco , Circunferência da Cintura/fisiologia
10.
PLoS One ; 16(7): e0254412, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34280195

RESUMO

BACKGROUND: Polycystic ovary syndrome (PCOS) affects up to 18% of reproductive-age females. The prevalence of obesity in PCOS patients reaches up to 80%, which is 2-fold higher than the general population. OBJECTIVE: The present study aimed to compare the effectiveness of 55 pharmacological interventions across 17 different outcomes in overweight/obese PCOS patients with hyperandrogenism manifestations for both short- and long-term follow-ups. A comprehensive literature search was performed on PubMed, Scopus, Embase, Science Direct, Web of Science, and Cochrane CENTRAL for randomized controlled trials comparing any conventional pharmacological intervention as a monotherapy or a combination in overweight/obese patients with polycystic ovary syndrome and hyperandrogenism manifestations. Extracted data included three main parameters; I. Anthropometric parameters (BMI, Waist and Hip circumferences, and Waist/HIP ratio), II. Hormonal parameters (FSH, LH, FSG, SHBG, Estradiol, Total Testosterone, Free testosterone, DHEAS, Androstenedione), and III. Metabolic parameters (Total Cholesterol, LDL-C, HDL-C, Triglycerides, Fasting glucose, Fasting glucose, HOMA-IR). Critical appraisal and risk of bias assessments were performed using the modified Jadad scale, and the overall quality of this network meta-analysis was evaluated according to the CINeMA framework. We performed both a pairwise meta-analysis and a network meta-analysis to evaluate the effect sizes with 95% CI, and we calculated the surface under the cumulative ranking curve (SUCRA) for each intervention. RESULTS: Our final search on May 15th 2021 retrieved 23,305 unique citations from searching six electronic databases. Eventually, 101 RCTs of 108 reports with a total of 8,765 patients were included in our systematic review and multi-treatments meta-analysis. 55 different interventions were included: 22 monotherapies, and 33 combinations. The two-dimensional cluster ranking of the average SUCRA values for metabolic and hormonal parameters with significant estimates revealed flutamide (77.5%, 70%; respectively) as the highest and rosiglitazone (38.2%, 26.3%; respectively) as the lowest, in terms of the overall efficacy in reducing weight and hyperandrogenism. However, cyproterone-acetate+ethinylestradiol exhibited a higher ranking in improving hormonal parameters (71.1%), but even a lower-ranking regarding metabolic parameters (34.5%). CONCLUSIONS AND RELEVANCE: Current evidence demonstrated the superiority of flutamide in improving both metabolic and hormonal parameters, and the higher efficacy of cyproterone-acetate+ethinylestradiol only in improving hormonal parameters. Nearly all interventions were comparable in female hormones, FGS, HDL, glucose, and insulin levels improvements.


Assuntos
Acetato de Ciproterona/uso terapêutico , Etinilestradiol/uso terapêutico , Hiperandrogenismo/sangue , Sobrepeso/sangue , Síndrome do Ovário Policístico/sangue , Adulto , Índice de Massa Corporal , LDL-Colesterol/sangue , Combinação de Medicamentos , Feminino , Humanos , Hiperandrogenismo/complicações , Hiperandrogenismo/tratamento farmacológico , Hiperandrogenismo/patologia , Metanálise em Rede , Obesidade , Sobrepeso/complicações , Sobrepeso/tratamento farmacológico , Sobrepeso/patologia , Síndrome do Ovário Policístico/complicações , Síndrome do Ovário Policístico/tratamento farmacológico , Síndrome do Ovário Policístico/patologia , Ensaios Clínicos Controlados Aleatórios como Assunto , Testosterona/sangue , Resultado do Tratamento , Triglicerídeos/sangue , Relação Cintura-Quadril
11.
Prensa méd. argent ; Prensa méd. argent;107(2): 61-65, 20210000. tab
Artigo em Inglês | LILACS, BINACIS | ID: biblio-1361274

RESUMO

Fundamento: los estudios sugieren la presencia de deficiencia de hierro en niños obesos, lo que conduciría a una mayor incidencia de anemia en este grupo. Objetivo: evaluar la prevalencia de anemia entre niños con sobrepeso y obesidad de dos niveles socioeconómicos y dos regiones diferentes en Brasil. Métodos: se obtuvieron datos de hemoglobina y antropometría de 598 niños y adolescentes con sobrepeso y obesidad de dos servicios especializados en la atención de estos niños. Resultados: la prevalencia global de anemia fue del 5,8% y el nivel medio de hemoglobina fue de 13,2 mg / dL, sin diferencia estadística para los dos indicadores según sobrepeso u obesidad y grupo de edad. Sin embargo, la hemoglobina media fue mayor entre los varones y, en el servicio con atención prestada a una población de menor nivel socioeconómico, la prevalencia de anemia fue mayor. Conclusión: la prevalencia de anemia encontrada en niños y adolescentes con sobrepeso y obesidad fue bastante baja, siendo mayor en la población más pobre. Para los niños y adolescentes con sobrepeso, la anemia parece estar más relacionada con el nivel socioeconómico que con la presencia de exceso de peso.


Background: studies suggest the presence of iron deficiency among obese children, which would lead to a higher incidence of anemia in this group. Aim: to assess the prevalence of anemia among overweight and obese children from two socioeconomic levels and two different regions in Brazil. Methods: hemoglobin and anthropometric data on 598 overweight and obese children and adolescents were obtained from two services specialized in the care of these children. Results: the overall prevalence of anemia was 5.8% and mean hemoglobin level was 13.2 mg/dL, with no statistical difference for the two indicators according to overweight or obesity and age group. However, the mean hemoglobin was higher among boys and, in the service with care provided to a population of lower socioeconomic status, the prevalence of anemia was higher. Conclusion: the prevalence of anemia found among overweight and obese children and adolescents was quite low, being higher in the poorest population. For overweight children and adolescents, anemia seems to be more related to socioeconomic status than to the presence of excess weight.


Assuntos
Humanos , Criança , Adolescente , Fatores Socioeconômicos , Áreas de Pobreza , Prevalência , Sobrepeso/patologia , Obesidade Infantil/patologia , Anemia/patologia
12.
Genes (Basel) ; 12(2)2021 02 19.
Artigo em Inglês | MEDLINE | ID: mdl-33669862

RESUMO

This study aims to identify the clinical and genetic markers related to the two uncommon nutritional statuses-metabolically unhealthy normal-weight (MUNW) and metabolically healthy overweight/obese (MHOW) individuals in the physically active individuals. Physically active male volunteers (n = 120) were recruited, and plasma samples were analyzed for the clinical parameters. Triglycerides, HDL-Cholesterol, LDL-cholesterol, total cholesterol, C-reactive protein, and insulin resistance were considered as markers of metabolic syndrome. The subjects were classified as 'healthy' (0 metabolic abnormalities) or 'unhealthy' (≥1 metabolic abnormalities) in their respective BMI group with a cut-off at 24.9 kg/m2. Analysis of biochemical variables was done using enzyme linked immunosorbent assay (ELISA) kits with further confirmation using western blot analysis. The microarray was conducted, followed by quantitative real-time PCR to identify and analyze differentially expressed genes (DEGs). The MHOW group constituted 12.6%, while the MUNW group constituted 32.4% of the total study population. Pro-inflammatory markers like interleukin-6, tumor necrosis factor (TNF)-α, and ferritin were increased in metabolically unhealthy groups in comparison to metabolically healthy groups. Gene expression profiling of MUNW and MHOW individuals resulted in differential expression of 7470 and 5864 genes, respectively. The gene ontology (GO) biological pathway analysis showed significant enrichment of the 'JAK/STAT signaling pathway' in MUNW and 'The information-processing pathway at the IFN-ß enhancer' pathway in MHOW. The G6PC3 gene has genetically emerged as a new distinct gene showing its involvement in insulin resistance. Biochemical, as well as genetic analysis, revealed that MUNW and MHOW are the transition state between healthy and obese individuals with simply having fewer metabolic abnormalities. Moreover, it is possible that the state of obesity is a biological adaptation to cope up with the unhealthy parameters.


Assuntos
Predisposição Genética para Doença , Glucose-6-Fosfatase/genética , Resistência à Insulina/genética , Síndrome Metabólica/genética , Obesidade/genética , Adulto , Biomarcadores/metabolismo , Índice de Massa Corporal , Proteína C-Reativa/genética , Feminino , Regulação da Expressão Gênica , Estudos de Associação Genética , Humanos , Interferon beta/genética , Masculino , Síndrome Metabólica/patologia , Obesidade/patologia , Sobrepeso/genética , Sobrepeso/patologia , Fenótipo , Medição de Risco , Fatores de Risco , Transdução de Sinais/genética
13.
Sci Rep ; 11(1): 6380, 2021 03 18.
Artigo em Inglês | MEDLINE | ID: mdl-33737627

RESUMO

Several early childhood obesity prediction models have been developed, but none for New Zealand's diverse population. We aimed to develop and validate a model for predicting obesity in 4-5-year-old New Zealand children, using parental and infant data from the Growing Up in New Zealand (GUiNZ) cohort. Obesity was defined as body mass index (BMI) for age and sex ≥ 95th percentile. Data on GUiNZ children were used for derivation (n = 1731) and internal validation (n = 713). External validation was performed using data from the Prevention of Overweight in Infancy Study (POI, n = 383) and Pacific Islands Families Study (PIF, n = 135) cohorts. The final model included: birth weight, maternal smoking during pregnancy, maternal pre-pregnancy BMI, paternal BMI, and infant weight gain. Discrimination accuracy was adequate [AUROC = 0.74 (0.71-0.77)], remained so when validated internally [AUROC = 0.73 (0.68-0.78)] and externally on PIF [AUROC = 0.74 [0.66-0.82)] and POI [AUROC = 0.80 (0.71-0.90)]. Positive predictive values were variable but low across the risk threshold range (GUiNZ derivation 19-54%; GUiNZ validation 19-48%; and POI 8-24%), although more consistent in the PIF cohort (52-61%), all indicating high rates of false positives. Although this early childhood obesity prediction model could inform early obesity prevention, high rates of false positives might create unwarranted anxiety for families.


Assuntos
Peso ao Nascer/fisiologia , Sobrepeso/epidemiologia , Obesidade Infantil/epidemiologia , Aumento de Peso/fisiologia , Peso ao Nascer/genética , Índice de Massa Corporal , Criança , Pré-Escolar , Estudos de Coortes , Pai , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Nova Zelândia/epidemiologia , Sobrepeso/genética , Sobrepeso/patologia , Ilhas do Pacífico/epidemiologia , Obesidade Infantil/genética , Obesidade Infantil/patologia , Gravidez , Fatores de Risco , Aumento de Peso/genética
14.
J Clin Endocrinol Metab ; 106(1): 174-187, 2021 01 01.
Artigo em Inglês | MEDLINE | ID: mdl-33098644

RESUMO

BACKGROUND: The enzyme 11ß-hydroxysteroid dehydrogenase type 1 (11ß-HSD1) determines prereceptor metabolism and activation of glucocorticoids within peripheral tissues. Its dysregulation has been implicated in a wide array of metabolic diseases, leading to the development of selective 11ß-HSD1 inhibitors. We examined the impact of the reversible competitive 11ß-HSD1 inhibitor, AZD4017, on the metabolic profile in an overweight female cohort with idiopathic intracranial hypertension (IIH). METHODS: We conducted a UK multicenter phase II randomized, double-blind, placebo-controlled trial of 12-week treatment with AZD4017. Serum markers of glucose homeostasis, lipid metabolism, renal and hepatic function, inflammation and androgen profiles were determined and examined in relation to changes in fat and lean mass by dual-energy X-ray absorptiometry. RESULTS: Patients receiving AZD4017 showed significant improvements in lipid profiles (decreased cholesterol, increased high-density lipoprotein [HDL] and cholesterol/HDL ratio), markers of hepatic function (decreased alkaline phosphatase and gamma-glutamyl transferase), and increased lean muscle mass (1.8%, P < .001). No changes in body mass index, fat mass, and markers of glucose metabolism or inflammation were observed. Patients receiving AZD4017 demonstrated increased levels of circulating androgens, positively correlated with changes in total lean muscle mass. CONCLUSIONS: These beneficial metabolic changes represent a reduction in risk factors associated with raised intracranial pressure and represent further beneficial therapeutic outcomes of 11ß-HSD1 inhibition by AZD4017 in this overweight IIH cohort. In particular, beneficial changes in lean muscle mass associated with AZD4017 may reflect new applications for this nature of inhibitor in the management of conditions such as sarcopenia.


Assuntos
Lipídeos/sangue , Músculos/efeitos dos fármacos , Niacinamida/análogos & derivados , Piperidinas/uso terapêutico , Pseudotumor Cerebral/tratamento farmacológico , 11-beta-Hidroxiesteroide Desidrogenase Tipo 1/antagonistas & inibidores , Adolescente , Adulto , Composição Corporal/efeitos dos fármacos , Método Duplo-Cego , Feminino , Humanos , Resistência à Insulina , Metabolismo dos Lipídeos/efeitos dos fármacos , Lipidômica , Pessoa de Meia-Idade , Músculos/diagnóstico por imagem , Músculos/metabolismo , Músculos/patologia , Niacinamida/farmacologia , Niacinamida/uso terapêutico , Obesidade/complicações , Obesidade/tratamento farmacológico , Obesidade/metabolismo , Obesidade/patologia , Tamanho do Órgão/efeitos dos fármacos , Sobrepeso/complicações , Sobrepeso/tratamento farmacológico , Sobrepeso/metabolismo , Sobrepeso/patologia , Piperidinas/farmacologia , Placebos , Pseudotumor Cerebral/complicações , Pseudotumor Cerebral/metabolismo , Pseudotumor Cerebral/patologia , Reino Unido , Adulto Jovem
15.
Peptides ; 135: 170433, 2021 01.
Artigo em Inglês | MEDLINE | ID: mdl-33129892

RESUMO

Central kisspeptin action is well known in reproductive regulation; however, its peripheral action is not well understood. This study aimed to 1) compare serum or cerebrospinal fluid (CSF) kisspeptin levels between different body mass index (BMI) groups 2) compare the levels of kisspeptin between serum and CSF, and 3) determine correlations between serum or CSF kisspeptin levels with clinical, metabolic, and reproductive parameters. There were 40 male subjects undergoing operations with lumbar puncture anesthesia. Subgroup analysis was performed to compare between the normal (n = 12), overweight (n = 10), and obese groups (n = 17). One lean subject was recruited for correlation analysis. Serum kisspeptin levels were significantly higher in the obese group when compared to the normal weight and overweight groups even after adjusting for age or diastolic blood pressure (DBP) (p < 0.05 all). Serum leptin levels were significantly higher in the obese group when compared to the normal weight and overweight groups (p < 0.05 all). CSF kisspeptin levels were below the minimum detectable concentration for the assay (<0.06 ng/mL). Serum kisspeptin was positively correlated with body weight, BMI, plasma insulin, the homeostatic model assessment for insulin resistance (HOMA-IR), and serum leptin but was negatively correlated with plasma LH (p < 0.05 all). In conclusion, serum kisspeptin was related to obesity, leptin, insulin, and insulin resistance, while CSF kisspeptin was below the limits of detection. Thus, peripheral kisspeptin might have a role in metabolic regulation.


Assuntos
Kisspeptinas/sangue , Kisspeptinas/líquido cefalorraquidiano , Leptina/sangue , Obesidade/genética , Reprodução/genética , Adulto , Anestesia , Índice de Massa Corporal , Peso Corporal/genética , Feminino , Humanos , Resistência à Insulina/genética , Kisspeptinas/genética , Leptina/genética , Masculino , Obesidade/sangue , Obesidade/líquido cefalorraquidiano , Obesidade/patologia , Sobrepeso/sangue , Sobrepeso/líquido cefalorraquidiano , Sobrepeso/genética , Sobrepeso/patologia , Punção Espinal/métodos
16.
PLoS One ; 15(11): e0241770, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-33186403

RESUMO

BACKGROUND: Many studies have investigated the prognosis of nonalcoholic fatty liver disease (NAFLD); however, most studies had a relatively short follow-up. To elucidate the long-term outcome of NAFLD, we conducted a retrospective cohort study of patients with biopsy-proven NAFLD. METHODS: We re-evaluated 6080 patients who underwent liver biopsy from 1975 to 2012 and identified NAFLD patients without other etiologies. With follow-up these patients, we evaluated the outcome-associated factors. RESULTS: A total of 223 patients were enrolled, 167 (74.9%) was non-alcoholic steatohepatitis (NASH). The median follow-up was 19.5 (0.5-41.0) years and 4248.3 person-years. The risk of type 2 diabetes mellitus (T2DM) and hypertension was 11.7 (95% confidence interval [CI] 8.70-15.6) and 7.99 (95% CI 6.09-10.5) times higher, respectively, in NAFLD patients than in the general population. Twenty-three patients died, 22 of whom had NASH. Major causes of death were extrahepatic malignancy and cardiovascular disease (21.7%) followed by liver-related mortality (13.0%). All-cause mortality was significantly higher in NASH patients than in nonalcoholic fatty liver patients (P = 0.041). In multivariate analysis, older age (hazard ratio [HR] 1.09 [95% CI 1.05-1.14], P<0.001) and T2DM (HR 2.87 [95% CI 1.12-7.04], P = 0.021) were significantly associated with all-cause mortality. The factors significantly associated with liver-related events were older age, T2DM, milder hepatic steatosis, and advanced liver fibrosis. Body mass index wasn't associated with either mortality or liver-related events. CONCLUSIONS: T2DM was highly prevalent in NAFLD patients and was significantly associated with both all-cause mortality and liver-related events. The lean patients' prognosis wasn't necessarily better than that of overweight patients.


Assuntos
Diabetes Mellitus Tipo 2/patologia , Hepatopatia Gordurosa não Alcoólica/patologia , Sobrepeso/patologia , Magreza/patologia , Adulto , Algoritmos , Biópsia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Mortalidade , Prognóstico , Estudos Retrospectivos
17.
In Vivo ; 34(5): 2873-2881, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32871827

RESUMO

BACKGROUND/AIM: To investigate the impact of body composition on morbidity and mortality at the initial diagnosis of localised renal cell carcinoma (RCC) in patients with overweight or obesity. PATIENTS AND METHODS: Sarcopenia was defined using sex-specific cut-off points and other body composition parameters by median values with computed tomography imaging. RESULTS: Among the 96 patients, 40 had sarcopenia (43.0%) at diagnosis. Body composition had no effect on morbidity and 5-year disease-free survival contrary to the classic factors (p<0.05). In the subgroup of obese patients, those with sarcopenia had a poor prognosis (p=0.04) but not in the population with overweight (p=0.9). CONCLUSION: Sarcopenia was frequently associated with localised RCC at the initial diagnosis. Body composition did not affect morbidity or outcomes. BMI was involved in morbidity and there was paradoxically longer survival in the obesity group.


Assuntos
Carcinoma de Células Renais , Neoplasias Renais , Sarcopenia , Composição Corporal , Índice de Massa Corporal , Carcinoma de Células Renais/complicações , Carcinoma de Células Renais/epidemiologia , Carcinoma de Células Renais/patologia , Feminino , Humanos , Neoplasias Renais/complicações , Neoplasias Renais/diagnóstico por imagem , Neoplasias Renais/epidemiologia , Masculino , Músculo Esquelético/patologia , Obesidade/complicações , Obesidade/epidemiologia , Obesidade/patologia , Sobrepeso/complicações , Sobrepeso/epidemiologia , Sobrepeso/patologia , Prognóstico , Sarcopenia/complicações , Sarcopenia/diagnóstico por imagem , Sarcopenia/epidemiologia
18.
Diabetes Metab Syndr ; 14(5): 1391-1397, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32755840

RESUMO

BACKGROUND AND OBJECTIVE: Overweight and obesity are thought to be associated with increased risk of chronic disease in the Middle East. The present study aimed to determine the association between dietary habits and the incidence of overweight and obesity in urban adult population in the central part of Iran after a 10-year follow-up. METHODS: This cohort study was initiated with 2000 participation aged 20-74 years from Yazd city in Iran based on Yazd Healthy Heart Project (YHHP). The participants without overweight and obesity at the baseline of the study were followed up to 10 years. Demographic data, anthropometric measurements, behavioral and metabolic risk factors of cardiovascular diseases and dietary habits were assessed at baseline and phase II. RESULTS: After a 10-year follow up, 516 non-overweight and 1068 non-obese participants were included for the final analysis. Once adjustments were made for all potential confounders including age, sex, smoking, economic status, physical activity and education, it was identified that lack of weight control increased the risk of obesity (hazard ratio; 95% CI) in total population (1.9; 1.06, 3.4), as well as the risk of overweight (2.39; 1.07, 5.27) and obesity (2.65; 1.13, 6.25) in men. Moreover, consumption of mayonnaise increased the 10-year risk of overweight in women (6.09; 1.2, 30.99). CONCLUSIONS: As revealed by the present study, unhealthy dietary habits can increase the incidence of overweight and obesity in central part of Iran. Therefore, changing the lifestyle appears to be urgent in reducing the risk of overweight and obesity.


Assuntos
Índice de Massa Corporal , Comportamento Alimentar , Estilo de Vida , Obesidade/epidemiologia , Sobrepeso/epidemiologia , Adulto , Idoso , Estudos de Coortes , Feminino , Seguimentos , Humanos , Incidência , Irã (Geográfico)/epidemiologia , Masculino , Pessoa de Meia-Idade , Obesidade/patologia , Sobrepeso/patologia , Prognóstico , Fatores de Risco , População Urbana , Adulto Jovem
19.
J Assist Reprod Genet ; 37(9): 2293-2304, 2020 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-32623663

RESUMO

PURPOSE: Women with polycystic ovary syndrome (PCOS) have an increased ovarian responsiveness to exogenous recombinant follicle stimulating hormone (rFSH) but also have high rates of obesity, which is known to affect serum FSH concentrations following exogenous injection. The purpose of this study was to compare rFSH absorption and ovarian response between lean and overweight/obese PCOS subjects and normo-ovulatory controls. METHODS: Fourteen women with PCOS aged 18-42 years old with a BMI of 18.5-24.9 kg/m2 (normal) or 25.0-40.0 kg/m2 (overweight/obese) and eleven normo-ovulatory controls matched by age and BMI were included. After downregulation with oral contraceptives, participants were administered a single subcutaneous injection of 225 IU rFSH and underwent serial blood draws over 72 h. RESULTS: Lean PCOS subjects exhibited a significantly higher area under the curve (AUC) of baseline-corrected serum FSH over 72 h when compared with overweight/obese PCOS subjects (183.3 vs 139.8 IU*h/L, p = 0.0002), and lean, normo-ovulatory women had a significantly higher AUC FSH when compared with overweight/obese, normo-ovulatory women (193.3 vs 93.8 IU*h/L, p < 0.0001). Within overweight/obese subjects, those with PCOS had a significantly higher AUC FSH compared with normo-ovulatory controls (p = 0.0002). Lean PCOS subjects similarly had the highest AUC of baseline-corrected estradiol (6095 pg h/mL), compared with lean normo-ovulatory subjects (1931 pg h/mL, p < 0.0001) and overweight/obese PCOS subjects (2337 pg h/mL, p < 0.0001). CONCLUSION: Lean PCOS subjects exhibited significantly higher baseline-corrected FSH and estradiol levels following rFSH injection compared with overweight/obese PCOS subjects with similar ovarian reserve markers. Amongst overweight/obese subjects, those with PCOS had significantly higher FSH and E2 levels when compared with normo-ovulatory controls.


Assuntos
Hormônio Foliculoestimulante Humano/administração & dosagem , Obesidade/tratamento farmacológico , Síndrome do Ovário Policístico/tratamento farmacológico , Proteínas Recombinantes/administração & dosagem , Adolescente , Adulto , Índice de Massa Corporal , Feminino , Hormônio Foliculoestimulante Humano/sangue , Humanos , Hormônio Luteinizante/sangue , Obesidade/sangue , Obesidade/complicações , Obesidade/patologia , Ovário/crescimento & desenvolvimento , Ovário/patologia , Sobrepeso/sangue , Sobrepeso/complicações , Sobrepeso/tratamento farmacológico , Sobrepeso/patologia , Síndrome do Ovário Policístico/sangue , Síndrome do Ovário Policístico/complicações , Síndrome do Ovário Policístico/patologia , Testosterona/sangue , Adulto Jovem
20.
J Korean Acad Nurs ; 50(3): 459-473, 2020 Jun.
Artigo em Coreano | MEDLINE | ID: mdl-32632078

RESUMO

PURPOSE: This study was conducted to identify the effects of a lifestyle intervention program on weight gain, dietary habits, fatigue and pregnancy stress, blood pressure, and neonatal birth weight, using Cox's interaction model of client health behavior for overweight and obese women. METHODS: This was a quasi-experimental research with a non-equivalent control group pre-post test design. A total of 52 patients who met the selection criteria, including 25 in the experimental group and 27 in the control group, were the subjects of the study; they comprised overweight and obese pregnant women who were receiving prenatal care at A and B women's hospital in J province. The lifestyle intervention program ran for 12 weeks in total and consisted of interactions involving affective support, health information, and professional/technical competencies. The data collection period was from February 1, 2017 to August 31, 2017. RESULTS: This study showed differences in the appropriate weight gain rate (χ²=6.17, p=.013), suppression of an increase in fatigue (t=-2.32, p=.012), and an increase in pregnancy stress (t=-1.87, p=.034). Yet, no differences in physical activity, dietary habits change, blood pressure, and neonatal birth weight (p>.05) were found. CONCLUSION: The study findings indicate that this program could be an effective intervention for the control of appropriate weight gain, fatigue, and pregnancy stress. Therefore, a lifestyle intervention program based on Cox's interaction model of client health behavior could be an efficient strategy for a positive health outcome of overweight and obesity pregnant women.


Assuntos
Estilo de Vida , Obesidade/prevenção & controle , Sobrepeso/prevenção & controle , Gestantes/psicologia , Avaliação de Programas e Projetos de Saúde , Adulto , Pressão Sanguínea , Exercício Físico , Fadiga , Comportamento Alimentar , Feminino , Humanos , Obesidade/patologia , Sobrepeso/patologia , Gravidez , Aumento de Peso , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA